Canada vs United States of America: Number of isolates tested for extended-spectrum cephalosporins
Canada
3,122
in 2018
United States of America
5,160
in 2018
Canada rank
3rd
United States of America rank
2nd
Number of isolates tested for extended-spectrum cephalosporins over time
- Canada
- United States of America
How they compare
United States of America currently reports 5,160 against 3,122 in Canada, a difference of 2,038.
That makes United States of America's figure about 1.7 times Canada's.
Across all 10 years both countries report, United States of America has been ahead every year.
Canada ranks 3rd and United States of America ranks 2nd of 51 countries.
United States of America has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Canada | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3,106 | 5,630 | 2,524 | United States of America |
| 2010s | 3,384 | 5,369 | 1,985 | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for extended-spectrum cephalosporins, Canada or United States of America?
- United States of America, at 5,160 against 3,122 in Canada as of 2018.
- What is the difference in number of isolates tested for extended-spectrum cephalosporins between Canada and United States of America?
- 2,038, with United States of America ahead.
- How many years of comparable data are there for Canada and United States of America?
- 10 years are reported by both, from 2009 to 2018.
- How do Canada and United States of America rank globally for number of isolates tested for extended-spectrum cephalosporins?
- Canada ranks 3rd and United States of America ranks 2nd of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for extended-spectrum cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.